AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases

Recruitingn/aAges 18 Years - 85 YearsAllXijing Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * available for 5 years of follow-up study Exclusion Criteria: * Death caused other than cardiovascular and cerebralvascular diseases till the study ends * Floating Population * Pregnancy, lactation, or child bearing women * Tumor * Active hepatic disease or hepatic dysfunction, or AST/ALT \> 1.5UNL * Severe renal dysfunction(Scr \> 3 mg/dl or 264ฮผmol/L) * Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Xijing Hospital
Xi'an, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy